Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VistaGen Therapeutics, Inc. | PRES./CHIEF SCIENTIFIC OFFICER | Common Stock | 65K | $112K | $1.72 | Dec 31, 2021 | Direct |
VistaGen Therapeutics, Inc. | PRES./CHIEF SCIENTIFIC OFFICER | Common Stock | 33.9K | $58.2K | $1.72 | Dec 31, 2021 | By H. Ralph Snodgrass Living Trust, dated 10/2/2008 |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTGN | VistaGen Therapeutics, Inc. | Dec 31, 2021 | 1 | $6.01K | 4 | Jan 3, 2022 | PRES./CHIEF SCIENTIFIC OFFICER |
VTGN | VistaGen Therapeutics, Inc. | Aug 23, 2021 | 2 | $0 | 4 | Sep 3, 2021 | PRES./CHIEF SCIENTIFIC OFFICER |
VTGN | VistaGen Therapeutics, Inc. | Aug 17, 2021 | 1 | $10.2K | 4 | Aug 18, 2021 | PRES./CHIEF SCIENTIFIC OFFICER |
VTGN | VistaGen Therapeutics, Inc. | Jun 30, 2021 | 1 | $6.6K | 4 | Jul 2, 2021 | PRES./CHIEF SCIENTIFIC OFFICER |